Abstract:Oncology drug efficacy is evaluated in mouse models by continuously monitoring tumor volumes, which can be mathematically described by growth kinetic models. Although past studies have investigated various growth models, their reliance on small datasets raises concerns about whether their findings are truly representative of tumor growth in diverse mouse models under different vehicle or drug treatments. In this study, we systematically evaluated six parametric models (exponential, exponential quadratic, monomolecular, logistic, Gompertz, and von Bertalanffy) and the semiparametric generalized additive model (GAM) on fitting tumor volume data from more than 30,000 mice in 930 experiments conducted in patient-derived xenografts, cell line-derived xenografts, and syngeneic models. We found that the exponential quadratic model is the best parametric model and can adequately model 87% studies, higher than other models including von Bertalanffy (82%) and Gompertz (80%) models; the latter is often considered the standard growth model. At the mouse group level, 7.5% of growth data could not be fit by any parametric model and were fitted by GAM. We show that endpoint gain integrated in time, a GAM-derived efficacy metric, is equivalent to exponential growth rate, a metric we previously proposed and conveniently calculated by simple algebra. Using five studies on paclitaxel, anti-PD1 antibody, cetuximab, irinotecan, and sorafenib, we showed that exponential and exponential quadratic models achieve similar performance in uncovering drug mechanism and biomarkers. We also compared exponential growth rate-based association analysis and exponential modeling approach in biomarker discovery and found that they complement each other. Modeling methods herein are implemented in an open-source R package freely available at https://github.com/hjzhou988/TuGroMix. Significance: We present a general strategy for mathematically modeling tumor growth in mouse models using data from 30,000 mice and show that modeling and nonmodeling approaches are complementary in biomarker discovery and drug mechanism studies.

Discrete ARMA Model Applied for Tumor Growth Inhibition Modeling and LQR-based Chemotherapy Optimization

A Comparative Analysis of ARX and ANFIS Models for Tumor Growth Prediction Under Single and Multi-agent Chemotherapy

A Mathematical Tumor Model with Immune Resistance and Drug Therapy: An Optimal Control Approach

Mathematical Modeling of Tumor Growth in Preclinical Mouse Models with Applications in Biomarker Discovery and Drug Mechanism Studies

A mathematical model to study the effects of drugs administration on tumor growth dynamics

Mathematical Modeling and Analysis of Tumor Chemotherapy

Mathematical analysis and simulation study of a phase-field model of prostate cancer growth with chemotherapy and antiangiogenic therapy effects

Multi-objective optimal chemotherapy control model for cancer treatment

Model based smooth super-twisting control of cancer chemotherapy treatment

Optimization and Scheduling for Chemotherapy Treatment to Control Tumour Growth

A Mathematical Model of Tumor‐Immune and Host Cells Interactions with Chemotherapy and Optimal Control

A Hybrid Cellular Automaton Model of Solid Tumor Growth and Bioreductive Drug Transport

Classical Mathematical Models for Description and Prediction of Experimental Tumor Growth

Optimal chemotherapy and immunotherapy schedules for a cancer-obesity model with Caputo time fractional derivative

Optimal control for cancer treatment mathematical model using Atangana–Baleanu–Caputo fractional derivative

Qualitative and Computational Analysis of a Mathematical Model for Tumor-Immune Interactions

Biomechanical modelling of tumor growth with chemotherapeutic treatment: A review

On a Mathematical Model Arising from an Optimal Chemotherapeutic Drug Treatment for Tumor Cells

Mathematical modeling of combined therapies for treating tumor drug resistance

Investigation of cancer response to chemotherapy: a hybrid multi-scale mathematical and computational model of the tumor microenvironment

A cellular automata model for avascular solid tumor growth under the effect of therapy